[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include Essential Pharmaceutical and LEC Custom Products.[ Price : $8.95]
FDA announces the fee rate for using a material threat medical countermeasure priority review voucher for fiscal year 2021.[ Price : $8.95]
Federal Register notice: FDA revokes the Emergency Use Authorizations issued to Autobio Diagnostics for the Anti-SARS-CoV2 Rapid T...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion sends Nalpropion Pharmaceuticals a Warning Letter related to a sponsored link appearin...[ Price : $8.95]
Federal Register notice: FDA postpones until further notice a 10/7 meeting of its Medical Devices Advisory Committees Circulatory ...[ Price : $8.95]
In a rare approval reversal, FDA issues a proposal to withdraw Amag Pharmaceuticals Makena because a required postmarket study fai...[ Price : $8.95]
FDA issues Nephron Pharmaceuticals the first Warning Letter citing a prescription drug manufacturer for promoting its product for ...[ Price : $8.95]
A new CDER investigation of real-world evidence confirms that patients taking levothyroxine benefit equally from generic and brand...